In summary, our observations demonstrated that the silencing of PROX1 expression strongly activates angiogenic markers in thyroid cancer cells, which reveals that PROX1 is involved in both processes: lymph- and angiogenesis. This evidence concerns the gene PROX1 and thyroid cancer.